NDAINJECTIONINJECTABLE
Approved
Jun 1971
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 11h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Capreomycin sulfate is an injectable cyclic peptide antibiotic approved in 1971 for treatment of drug-resistant tuberculosis (TB), particularly multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) strains. It is administered intramuscularly and works by inhibiting bacterial protein synthesis. The drug is used as a second-line agent in combination regimens for TB infections resistant to first-line agents.
LOE Approaching
Modest commercial footprint with LOE approaching signals a small, stable team focused on market maintenance rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Capastat Sulfate offers experience in rare disease/niche market management and second-line therapy positioning within a mature product lifecycle. This role is best suited for professionals interested in established product stewardship and strategic planning for products facing LOE rather than high-growth commercialization.
Brand ManagerSales Representative
Worked on CAPASTAT SULFATE at Fosun Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.